We are live on ! Find out more
EEG

E.E. Geduld Portfolio holdings

AUM $178M
1-Year Est. Return 29.34%
This Fund
S&P 500
This Quarter Est. Return
-7.61%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$107M
AUM Growth
-$54.2M
Cap. Flow
-$24M
Cap. Flow %
-22.49%
Top 10 Hldgs %
54.93%
Holding
347
New
45
Increased
19
Reduced
60
Closed
132
Avg Time Held Equity + Options
4.4 quarters
Top 10 Avg Time Held Equity + Options
2.2 quarters
Top 20 Avg Time Held Equity + Options
2.4 quarters
Avg Time Held Equity only
4.6 quarters
Top 10 Avg Time Held Equity only
3.6 quarters
Top 20 Avg Time Held Equity only
3.2 quarters

Sector Composition

Rank Sector Weight
1 Financials 45.84%
2 Miscellaneous 25.05%
3 Healthcare 9.93%
4 Consumer Discretionary 6.85%
5 Technology 4.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
WIFI
101
CALL
DELISTED
Boingo Wireless, Inc.
WIFI
$142K 0.13%
+17,200
New +$147K
2015 Q3
0 quarters
ASNA
102
DELISTED
Ascena Retail Group, Inc.
ASNA
$139K 0.13%
500
-250
-33% -$65.3K
2015 Q2
1 quarter
EBSB
103
DELISTED
Meridian Bancorp, Inc.
EBSB
$137K 0.13%
10,000
– –
2014 Q3
4 quarters
ICON icon
104
DELISTED
Iconix Brand Group, Inc.
ICON
$135K 0.13%
+1,000
New +$173K
2015 Q3
0 quarters
AVHI
105
DELISTED
A V Homes, Inc.
AVHI
$135K 0.13%
10,000
– –
2013 Q2
9 quarters
LL icon
106
DELISTED
LL Flooring Holdings, Inc.
LL
$131K 0.12%
10,000
-15,000
-60% -$246K
2015 Q1
2 quarters
IBN icon
107
ICICI Bank
IBN
$101B
$126K 0.12%
16,500
– –
2014 Q2
5 quarters
RAVE icon
108
RAVE Restaurant Group
RAVE
$32M
$115K 0.11%
13,500
-1,500
-10% -$17K
2014 Q4
3 quarters
SANW icon
109
DELISTED
S&W Seed Co
SANW
$115K 0.11%
1,316
– –
2015 Q1
2 quarters
EGIO icon
110
DELISTED
Edgio, Inc. Common Stock
EGIO
$105K 0.1%
1,375
+1,125
+450% +$138K
2015 Q2
1 quarter
TLN icon
111
DELISTED
Talen Energy Corporation
TLN
$101K 0.09%
+10,000
New +$147K
2015 Q3
0 quarters
NG icon
112
NovaGold Resources
NG
$2.95B
$90K 0.08%
25,000
-50,000
-67% -$169K
2014 Q1
6 quarters
IOVA icon
113
Iovance Biotherapeutics
IOVA
$6.6B
$86K 0.08%
15,000
-45,000
-75% -$350K
2015 Q1
2 quarters
CRIS icon
114
Curis
CRIS
$1.56M
$81K 0.08%
20
-18
-47% -$102K
2013 Q2
9 quarters
FCEL icon
115
FuelCell Energy
FCEL
$1.31B
$81K 0.08%
25
– –
2013 Q3
8 quarters
EVFM
116
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$81K 0.08%
111
-167
-60% -$179K
2015 Q2
1 quarter
GSAT icon
117
Globalstar
GSAT
$10.8B
$79K 0.07%
3,333
+1,666
+100% +$47K
2013 Q4
7 quarters
FCSC
118
DELISTED
Fibrocell Science Inc.
FCSC
$77K 0.07%
1,340
-1,327
-50% -$117K
2013 Q4
7 quarters
PCYO icon
119
Pure Cycle
PCYO
$271M
$74K 0.07%
15,000
– –
2013 Q2
9 quarters
NVCN
120
DELISTED
Neovasc Inc.
NVCN
$74K 0.07%
1
– –
2014 Q2
5 quarters
TXMD icon
121
TherapeuticsMD
TXMD
$23.4M
$73K 0.07%
250
-350
-58% -$124K
2015 Q2
1 quarter
ROX
122
DELISTED
Castle Brands, Inc.
ROX
$66K 0.06%
50,000
+25,000
+100% +$31.4K
2013 Q2
9 quarters
MPVD
123
DELISTED
Mountain Province Diamonds Inc.
MPVD
$65K 0.06%
25,000
– –
2015 Q2
1 quarter
LINDW icon
124
DELISTED
Lindblad Expeditions Holdings Inc. Warrant
LINDW
$65K 0.06%
+35,000
New +$62.2K
2015 Q3
0 quarters
ZNGA
125
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$57K 0.05%
+25,000
New +$63.9K
2015 Q3
0 quarters

Similar funds

E.E. Geduld's Q3 2015 Portfolio in Review

As of Q3 2015, E.E. Geduld held 347 positions worth $107M, down 34% from $161M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

E.E. Geduld withdrew a net $24M in Q3 2015, closing 132 positions and reducing 60 holdings. Its most notable exit was bluebird bio, an estimated $1.75M position sold in full.

By sector, the portfolio is most concentrated in Financials at 46% of assets, up from 33% a quarter earlier, followed by Miscellaneous and Healthcare.

Against the trend, E.E. Geduld opened a new position in Bristol-Myers Squibb worth $1.48M.

  • E.E. Geduld's largest Q3 2015 buy was Bristol-Myers Squibb: 25,000 shares worth $1.48M.
  • E.E. Geduld added most to Amazon in Q3 2015, an estimated $758K increase.
  • E.E. Geduld's biggest Q3 2015 reduction was Ariad Pharmaceuticals Inc, cutting an estimated $578K.
  • E.E. Geduld fully exited bluebird bio in Q3 2015, selling an estimated $1.75M.
  • E.E. Geduld's ten largest holdings make up 55% of its $107M portfolio in Q3 2015.
  • E.E. Geduld opened 45 new positions and closed 132 in Q3 2015.
  • E.E. Geduld's portfolio value fell 34% quarter-over-quarter to $107M.

Based on E.E. Geduld's 13F filing for Q3 2015, filed 6 Nov 2015.